Supporting this mechanism, recent studies have highlighted the pivotal role of S100A9 in carcinogenesis, associating it with the dysregulated differentiation of myeloid cells within the tumor stroma and its involvement in the progression of leukemia [69]. Here, S100A9 is linked to leukemia.